01.02.2019: New Application Note showing P2X2/3 recorded on the SyncroPatch 384PE with 97% success rates now available!
We have recorded P2X2/3 expressed in CHO cells from Axxam S.p.A., Milan on the SyncroPatch 384PE with success rates of over 97% for completed, full concentration response curves on each well. Cells were stable for 45 minutes on the SyncroPatch 384PE and P2X2/3 could be repetitively and reproducibly activated, control peak amplitudes varied by just 5%. Find your next pain therapeutic using the SyncroPatch 384PE!
Download the Application Note here.